Testing one blood thinner instead of two after a heart attack

This study is testing whether ticagrelor—a blood-thinning medication—works better when taken alone instead of combined with aspirin in people who have had a heart attack and are being managed with medication rather than a procedure. The trial wants to see if using just one blood thinner can reduce serious bleeding while still preventing future heart attacks and other complications.

After a heart attack, doctors typically prescribe two blood-thinning medications to prevent another event, but this combination increases the risk of dangerous bleeding. This study aims to find out if the medication alone might provide better protection by reducing bleeding risk without putting patients at higher risk for another heart attack.